FDG-PET in the diagnosis of primary progressive aphasia: a systematic review

Ann Nucl Med. 2024 Sep;38(9):673-687. doi: 10.1007/s12149-024-01958-w. Epub 2024 Jul 19.

Abstract

Primary progressive aphasia (PPA) is a disease known to affect the frontal and temporal regions of the left hemisphere. PPA is often an indication of future development of dementia, specifically semantic dementia (SD) for frontotemporal dementia (FTD) and logopenic progressive aphasia (LPA) as an atypical presentation of Alzheimer's disease (AD). The purpose of this review is to clarify the value of 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-positron emission tomography (PET) in the detection and diagnosis of PPA. A comprehensive review of literature was conducted using Web of Science, PubMed, and Google Scholar. The three PPA subtypes show distinct regions of hypometabolism in FDG-PET imaging with SD in the anterior temporal lobes, LPA in the left temporo-parietal junction, and nonfluent/agrammatic Variant PPA (nfvPPA) in the left inferior frontal gyrus and insula. Despite the distinct patterns, overlapping hypometabolic areas can complicate differential diagnosis, especially in patients with SD who are frequently diagnosed with AD. Integration with other diagnostic tools could refine the diagnostic process and lead to improved patient outcomes. Future research should focus on validating these findings in larger populations and exploring the therapeutic implications of early, accurate PPA diagnosis with more targeted therapeutic interventions.

Keywords: 2-deoxy-2-[18F]fluoro-D-glucose; FDG; Neurology; PET; Positron emission tomography; Primary progressive aphasia.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Aphasia, Primary Progressive* / diagnostic imaging
  • Fluorodeoxyglucose F18*
  • Humans
  • Positron-Emission Tomography* / methods

Substances

  • Fluorodeoxyglucose F18